The effect of soy isoflavones on serum concentration of cell adhesion molecules among postmenupausal women: A systematic review and meta-analysis on randomized clinical

Authors
Abstract
Introduction

New evidence indicates the anti-inflammatory effects of soy isoflavones. The purpose of this study is to conduct a systematic review and meta-analysis of clinical trial articles on the effect of soy isoflavones on the serum levels of adhesive molecules in postmenopausal women.

Method and material

In this study, the Clinicaltrials.gov database, ISI web of Science, Cochrane Library, PubMed, and Scopus will be searched until December 2020, and all studies that examine soy isoflavones effect on the serum levels of E-selectin, Intracellular Adhesion Molecule 1 (ICAM-1) and vascular adhesion molecule-1 (VCAM-1) has been selected. DerSimonian and Laird's random-effects model was used to estimate the summary of the overall effects (MDs) and its heterogeneity. Cochran's Q test and I-squared statistic were used to compute the statistical heterogeneity of intervention effects.

Results

Three randomized clinical trials on 297 patients investigated the effect of soy isoflavones on serum levels of adhesive molecules in postmenopausal women. The results of meta-analysis showed that taking soy isoflavones supplementation reduced the serum levels of E-selectin, ICAM-1 and VCAM-1 by 10.26 ng/ml, 2.11 ng / ml, and 13.17 ng/ml, respectively. They were not statistically significant (P> 0.05).

Conclusion

According to the results of this study, soy isoflavones cause a significant decrease in serum levels of E-selectin, ICAM-1 and VCAM-1. However, more studies are needed, with larger sample size and longer intervention time.
Keywords

1. Farmer JA, Torre-Amione G. The renin angiotensin system as a risk factor for coronary artery disease. Current atherosclerosis reports. 2001;3(2):117-24
2. Yamamoto K, Ando J. New molecular mechanisms for cardiovascular disease:blood flow sensing mechanism in vascular endothelial cells. Journal of pharmacological sciences. 2011;116(4):323-31.
3. Schleimer RP, Rutledge BK. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. Journal of immunology (Baltimore, Md : 1950). 1986;136(2):649-54.
4. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature reviews Immunology. 2007;7(9):678-89.
5. Haghighatdoost F, Hariri M. Can resveratrol supplement change inflammatory mediators? A systematic review and meta-analysis on randomized clinical trials. European journal of clinical nutrition. 2019;73(3):345-55.
6. Haghighatdoost F, Hariri M. The effect of alpha-lipoic acid on inflammatory mediators: a systematic review and meta-analysis on randomized clinical trials. European journal of pharmacology. 2019;849:115-23.
7. Michalsen A, Lehmann N, Pithan C, Knoblauch NT, Moebus S, Kannenberg F, et al. Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease. European journal of clinical nutrition. 2006;60(4):478-85.
8. King DE. Dietary fiber, inflammation, and cardiovascular disease. Molecular nutrition & food research. 2005;49(6):594-600.
9. Khiaosa-Ard R, Zebeli Q. Diet-induced inflammation: From gut to metabolic organs and the consequences for the health and longevity of ruminants. Research in veterinary science. 2018;120:17-27.
10. Ramdath DD, Padhi EMT, Sarfaraz S, Renwick S, Duncan AM. Beyond the Cholesterol-Lowering Effect of Soy Protein: A Review of the Effects of Dietary Soy and Its Constituents on Risk Factors for Cardiovascular Disease. Nutrients. 2017;9(4).
11. Dettmer M, Alekel DL, Lasrado JA, Messina M, Carriquiry A, Heiberger K, et al. The effect of soy protein beverages on serum cell adhesion molecule concentrations in prehypertensive/stage 1 hypertensive individuals. J Am Coll Nutr. 2012;31(2):100-10.
12. Atteritano M, Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. The Journal of clinical endocrinology and metabolism. 2007;92(8):3068-75.
13. Hong J, Kim S, Kim HS. Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein Kinase alpha Pathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease. J Med Food. 2016;19(6):549-59.
14. Serrano JC, Martín-Gari M, Cassanye A, Granado-Serrano AB, Portero-Otín M. Characterization of the post-prandial insulinemic response and low glycaemic index of a soy beverage. PloS one. 2017;12(8):e0182762.
15. Schwingshackl L, Bogensberger B, Bencic A, Knuppel S, Boeing H, Hoffmann G. Effects of oils and solid fats on blood lipids: a systematic review and network meta-analysis. Journal of Lipid Research. 2018;59(9):1771-82.
16. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation. 2006;113(7):1034-44.
17. Miyamoto N, Mandai M, Suzuma I, Suzuma K, Kobayashi K, Honda Y. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. Journal of immunology (Baltimore, Md : 1950). 1999;163(1):374-9.
18. Pfeilschifter J, Köditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocrine reviews. 2002;23(1):90-119.
19. Hernandez-Ledesma B, Hsieh CC, de Lumen BO. Chemopreventive properties of Peptide Lunasin: a review. Protein and peptide letters. 2013;20(4):424-32.
20. Hematdar Z, Ghasemifard N, Phishdad G, Faghih S. Substitution of red meat with soybean but not non- soy legumes improves inflammation in patients with type 2 diabetes; a randomized clinical trial. J Diabetes Metab Disord. 2018;17(2):111-6.
21. Higgins J, Green S. Cochrane Handbook for Systematic Reviews, version 5.0.2 The Cochrane Collaboration: Joh Wiley & Sons Ltd; 2009.
22. Higgins JP, Thomas J. Cochrane handbook for systematic reviews of interventions: wiley blackwell; 2020.
23. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC medical research methodology. 2005;5(1):13.
24. Colacurci N, Chiàntera A, Fornaro F, De Novellis V, Manzella D, Arciello A, et al. Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Menopause. 2005;12(3):299-307.
25. Hall WL, Vafeiadou K, Hallund J, Bügel S, Koebnick C, Reimann M, et al. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: Interactions with genotype and equol production. American Journal of Clinical Nutrition. 2005;82(6):1260-8.
26. Liu ZM, Ho SC, Chen YM, Woo J. Effect of soy protein and isoflavones on blood pressure and endothelial cytokines: a 6-month randomized controlled trial among postmenopausal women. Journal of hypertension. 2013;31(2):384-92.
27. Liu L, Yang T, Simon SA. The protein tyrosine kinase inhibitor, genistein, decreases excitability of nociceptive neurons. Pain. 2004;112(1-2):131-41.
28. Mueller SO, Simon S, Chae K, Metzler M, Korach KS. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicological sciences : an official journal of the Society of Toxicology. 2004;80(1):14-25.
29. Comalada M, Ballester I, Bailón E, Sierra S, Xaus J, Gálvez J, et al. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochemical pharmacology. 2006;72(8):1010-21.
30. Lee Y, Cha YS, Park Y, Lee M. PPAR gamma 2 C1431T Polymorphism Interacts with the Antiobesogenic Effects of Kochujang, a Korean Fermented, Soybean-Based Red Pepper Paste, in Overweight/Obese Subjects: A 12-Week, Double-Blind Randomized Clinical Trial. Journal of Medicinal Food. 2017;20(6):610-7.
31. Khodarahmi M, Jafarabadi MA, Moludi J, Farhangi MA. A systematic review and meta-analysis of the effects of soy on serum hs-CRP. Clinical Nutrition. 2019;38(3):996-1011.
32. Setchell KDR. The history and basic science development of soy isoflavones. Menopause-the Journal of the North American Menopause Society. 2017;24(12):1338-50.
33. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Soy consumption, markers of inflammation, and endothelial function - A cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care. 2007;30(4):967-73.
34. Rebholz CM, Reynolds K, Wofford MR, Chen J, Kelly TN, Mei H, et al. Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial. Eur J Clin Nutr. 2013;67(1):58-63.
35. Acharjee S, Zhou JR, Elajami TK, Welty FK. Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status. Metabolism. 2015;64(2):236-43.